Found 7 matching trials
The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps PHASE2 This is an open-label, single-arm, multicenter, extension study to evaluate...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of IL4RΞ± Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis PHASE3 Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of ...
Show More Location
Zhongnan Hospital of Wuhan university
Learn More & Join Trial
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps PHASE2 This is a multi-center, randomized, double blind, placebo-controlled study ...
Show More Location
Beijing Tongren Hospital
Learn More & Join Trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma PHASE2 This is a multi-center, randomized, double blind, placebo-controlled study ...
Show More Location
The First Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis PHASE3 This is a multi-center, randomized, double blind, placebo-controlled study ...
Show More Learn More & Join Trial
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. PHASE3 Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of ...
Show More Location
Zhongnan Hospital of Wuhan university
Learn More & Join Trial
A Study of IL4RΞ± Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). PHASE2 Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of ...
Show More Status
Active Not Recruiting
Location
Hebei Petro China Central Hospital
Learn More & Join Trial